An experimental medication that could become the first drug derived from a marijuana plant approved in the U.S. received a boost from Food and Drug Administration staff.

The treatment’s maker, U.K. company GW Pharmaceuticals Plc, provided “substantial evidence” of the drug’s effectiveness, FDA staff said in a report released Tuesday.

The medication would treat seizures associated with two rare forms of epilepsy that typically affect children, according to the report. 

Click here to read the complete article

Anna Edney ~ Bloomberg.com

Recent News Articles

Wednesday November 14

Marijuana conference MJBizCon draws 25,000 in Las Vegas - Cannabis News

in Cannabis News

by Bruce Kennedy - Editor in Chief

The number of exhibitors this year has jumped almost 50 percent from 2017. Attendance has…

1142 hits

Wednesday November 14

The Future of Cannabis at Concerts Explored at Billboard's Live Music Summit - Cannabis News

in Entertainment

by Bruce Kennedy - Editor in Chief

Non-combustibles may be the future of cannabis at live events.

1324 hits

Wednesday November 14

Bipartisan Lawmakers Introduce Three Medical Marijuana Bills For Veterans - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

A bipartisan team of lawmakers plans to introduce a package of bills aimed at reforming…

1222 hits

Wednesday November 14

Cannabis and Epilepsy Symposium in Denver During Epilepsy Awareness Month - Cannabis News

in Medical News

by Bruce Kennedy - Editor in Chief

Nearly a dozen doctors and attorneys specializing in cannabis policy and research, as well as…

1213 hits

Thursday November 15

Politics: Marijuana backers plot ambitious campaign - Cannabis News

in Politics

by Bruce Kennedy - Editor in Chief

Advocates of legalizing medical and recreational marijuana are planning a wave of new ballot measures…

992 hits